A detailed history of Antipodes Partners LTD transactions in Ventas, Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 1,449,916 shares of VTR stock, worth $92.2 Million. This represents 3.29% of its overall portfolio holdings.

Number of Shares
1,449,916
Previous 1,434,198 1.1%
Holding current value
$92.2 Million
Previous $73.5 Million 26.5%
% of portfolio
3.29%
Previous 2.71%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$50.88 - $65.33 $799,731 - $1.03 Million
15,718 Added 1.1%
1,449,916 $93 Million
Q2 2024

Aug 05, 2024

BUY
$41.68 - $51.26 $59.8 Million - $73.5 Million
1,434,198 New
1,434,198 $73.5 Million

Others Institutions Holding VTR

About Ventas, Inc.


  • Ticker VTR
  • Exchange NYSE
  • Sector Real Estate
  • Industry REIT—Healthcare Facilities
  • Shares Outstandng 399,712,992
  • Market Cap $25.4B
  • Description
  • Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries ? healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institution...
More about VTR
Track This Portfolio

Track Antipodes Partners LTD Portfolio

Follow Antipodes Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Antipodes Partners LTD with notifications on news.